Chitosan nanoparticles for mucosal and needle-free vaccination

Area of Science:

• Biomaterials Science
• Immunology
• Nanotechnology

Background:

• Chitosan nanoparticles (CNPs) are gaining attention as advanced vaccine carriers.
• They offer benefits like improved antigen stability, enhanced mucosal delivery, and stronger immune activation.
• CNPs are being explored for various vaccine types, including inactivated, subunit, and nucleic acid vaccines.

Purpose of the Study:

• To review the biological functions, chemical engineering, fabrication, and performance of chitosan nanoparticles in vaccine applications.
• To define structure-function principles for rational design of thermostable and effective chitosan nanoparticle-based vaccines.
• To highlight the potential of needle-free mucosal vaccination using CNPs for scalable deployment.

Main Methods:

• Literature review synthesizing current research on chitosan nanoparticles for vaccines.
• Analysis of biological functions, chemical engineering, and fabrication techniques.
• Evaluation of performance data across different vaccine types (inactivated, subunit, nucleic acid).

Main Results:

• Chitosan nanoparticles demonstrate versatility as vaccine carriers, improving antigen stability and immune activation.
• Rational design principles based on structure-function relationships are emerging for thermostable vaccines.
• Needle-free mucosal delivery using CNPs shows promise for scalable and accessible immunization strategies.

Conclusions:

• Chitosan nanoparticles represent a significant advancement in vaccine carrier technology.
• Understanding structure-function principles is key to developing effective and stable nanoparticle vaccines.
• The potential for needle-free mucosal vaccination offers a scalable solution for global health challenges.